To Prevent Shortages, US FDA Wants Sponsor To Provide Notifications Of Demand Spike
Executive Summary
Demand-related shortages are a relatively new problem, but the FDA maintains their tools can prevent or end them.
You may also be interested in...
As COVID Public Health Emergency Winds Down, US FDA Employs Flexibility For Rx EUA Transitions
Biden administration sets May 11 as end date for public health emergency. CDER has said it will work with sponsors to help them gain approval of COVID therapeutics cleared under emergency use authorizations, but agency will likely not issue a formal transition framework.
Supply Chain Conversations Should Continue, But Industry Wants More Government Transparency
Healthcare Distribution Alliance CEO Chip Davis says drug wholesalers and suppliers need the government’s information on product demand, just as the government needs industry inventory data, to anticipate and avert shortages.
Demand Spike Sees Sandoz, Teva Fall Short On US Amoxicillin Supply
Infants and young children across the US are continuing to struggle to get access to one of the most common and recognized antibiotics, liquid-dose amoxicillin, amid a surge in demand for the drug that has hindered generics manufacturers.